Objectives

1. Describe the fundamental paradigm shift in type 2 diabetes management

2. List several classes glucose-lowering medications with proven benefits in improving cardiovascular outcomes

3. Articulate key messages from current practice guidelines for patients with type 2 diabetes and cardiovascular disease

Session date: 
Friday, May 31, 2019 - 8:00am to 9:00am
Speaker Name: 
Mikhail Kosiborod, MD, FACC, FAHA
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.